Publications by authors named "Julia Worm"

Article Synopsis
  • A Canadian trial found that oral micronized progesterone is more effective than placebo in reducing vasomotor symptoms (VMS) in postmenopausal women, with a dose-dependent improvement observed over 12 weeks.
  • The study involved 74 women and tested three doses (200mg, 300mg, 400mg) of progesterone alongside placebo, but 44 participants dropped out, leading to a low final analysis group of 55.
  • While most adverse events were minor, the trial's findings on VMS reduction were influenced by differences in study populations, with the placebo group showing a greater decline in VMS frequency than expected due to low participant accrual.
View Article and Find Full Text PDF